Ozair Naqvi

Mr. Ozair Naqvi

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
GDGargi N Deshpande
Gargi N Deshpande
JBJessica Beetch
Jessica Beetch
JHJohn Grady Heller
John Grady Heller
ONOzair Naqvi
Ozair Naqvi
KKKatrin Gaardbo Kuhn
Katrin Gaardbo Kuhn
In the United States (US), tick-borne diseases (TBDs) have more than doubled in the past fifteen years and are a major contributor to the overall burden of vector-borne diseases. The most common TBDs in the US—Lyme disease, rickettsioses (including Rocky Mountain spotted fever), and anaplasmosis—have gradually shifted in recent years, resulting in increased morbidity and mortality. In this systematic review, we examined climate change and other environmental factors that have influenced the epidemiology of these TBDs in the US while highlighting the opportunities for a One Health approach to mitigating their impact. We searched Medline Plus, PUBMED, and Google Scholar for studies focused on these three TBDs in the US from January 2018 to August 2023. Data selection and extraction were completed using Covidence, and the risk of bias was assessed with the ROBINS-I tool. The review included 84 papers covering multiple states across the US. We found that climate, seasonality and temporality, and land use are important environmental factors that impact the epidemiology and patterns of TBDs. The emerging trends, influenced by environmental factors, emphasize the need for region-specific research to aid in the prediction and prevention of TBDs.

12 October 2022 in The Journal of School Nursing
Verified
Journal Article
Closed access
ONOzair Naqvi
Ozair Naqvi
AWAaron M. Wendelboe
Aaron M. Wendelboe
LBLaurence Burnsed
Laurence Burnsed
MMMike Mannell
Mike Mannell
AJAmanda Janitz
Amanda Janitz
SNStephanie Natt
Stephanie Natt
Recent trends in vaccine hesitancy have brought to light the importance of using accurate school vaccination data. This study evaluated the accuracy of a pilot statewide kindergarten vaccination survey in Oklahoma. School vaccination and exemption data were collected from November 2017 to April 2018 via the Research Electronic Data Capture system. A multivariable linear regression model was used to evaluate the relationship between students who are up to date for all vaccines comparing school reported and Oklahoma State Department of Health-validated data. Adjusted vaccination data were overestimated by 1.0% among public schools and 3.3% among private schools. These results were validated by a random audit of participating schools finding the school-reported vaccination data to be overestimated by 0.6% compared to true student immunization records on file. Our analysis indicates that school-reported vaccination data are sufficiently valid. Immunization record audits provide confidence in available data, which drives evidence-based decision-making.

29 March 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
ADAlicia Dunajcik
Alicia Dunajcik
KHKambria Haire
Kambria Haire
JTJennifer D Thomas
Jennifer D Thomas
LMLeah F Moriarty
Leah F Moriarty
YSYuri Springer
Yuri Springer
MAMark Anderson
Mark Anderson
The first three SARS-CoV-2 phylogenetic lineages classified as variants of concern (VOCs) in the United States (U.S.) from December 15, 2020 to February 28, 2021, Alpha (B.1.1.7), Beta (B.1.351), and Gamma (P.1) lineages, were initially detected internationally. This investigation examined available travel history of coronavirus disease 2019 (COVID-19) cases reported in the U.S. in whom laboratory testing showed one of these initial VOCs. Travel history, demographics, and health outcomes for a convenience sample of persons infected with a SARS-CoV-2 VOC from December 15, 2020 through February 28, 2021 were provided by 35 state and city health departments, and proportion reporting travel was calculated. Of 1,761 confirmed VOC cases analyzed, 1,368 had available data on travel history. Of those with data on travel history, 1,168 (85%) reported no travel preceding laboratory confirmation of SARS-CoV-2 and only 105 (8%) reported international travel during the 30 days preceding a positive SARS-CoV-2 test or symptom onset. International travel was reported by 92/1,304 (7%) of persons infected with the Alpha variant, 7/55 (22%) with Beta, and 5/9 (56%) with Gamma. Of the first three SARS-CoV-2 lineages designated as VOCs in the U.S., international travel was common only among the few Gamma cases. Most persons infected with Alpha and Beta variant reported no travel history, therefore, community transmission of these VOCs was likely common in the U.S. by March 2021. These findings underscore the importance of global surveillance using whole genome sequencing to detect and inform mitigation strategies for emerging SARS-CoV-2 VOCs.

9 May 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AWAaron M. Wendelboe
Aaron M. Wendelboe
ONOzair Naqvi
Ozair Naqvi
MWMary B. Williams
Mary B. Williams
HHHeather Hollen
Heather Hollen
KMKaitlin McGrew
Kaitlin McGrew
ACAnn F Chou
Ann F Chou
Objectives: Outbreaks of injection drug use (IDU)-associated infections have become major public health concerns in the era of the opioid epidemic. This study aimed to (1) identify county-level characteristics associated with acute HCV infection and newly diagnosed IDU-associated HIV in Oklahoma and (2) develop a vulnerability index using these metrics. Methods: This study employs a county-level ecological design to examine those diagnosed with acute or chronic HCV or newly diagnosed IDU-associated HIV. Poisson regression was used to estimate the association between indicators and the number of new infections in each county. Primary outcomes were acute HCV and newly diagnosed IDU-associated HIV. A sensitivity analysis included all HCV (acute and chronic) cases. Three models were run using variations of these outcomes. Stepwise backward Poisson regression predicted new infection rates and 95% confidence intervals for each county from the final multivariable model, which served as the metric for vulnerability scores. Results: Predictors for HIV-IDU cases and acute HCV cases differed. The percentage of the county population aged 18–24 years with less than a high school education and population density were predictive of new HIV-IDU cases, whereas the percentage of the population that was male, white, Pacific Islander, two or more races, and people aged 18–24 years with less than a high school education were predictors of acute HCV infection. Counties with the highest predicted rates of HIV-IDU tended to be located in central Oklahoma and have higher population density than the counties with the highest predicted rates of acute HCV infection. Conclusions: There is high variability in county-level factors predictive of new IDU-associated HIV infection and acute HCV infection, suggesting that different public health interventions need to be tailored to these two case populations.

29 July 2026 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
ONOzair Naqvi
Ozair Naqvi
AWAaron M. Wendelboe
Aaron M. Wendelboe
WBWilliam H. Beasley
William H. Beasley
DTDonna L. Tyungu
Donna L. Tyungu
KDKai Ding
Kai Ding
AJAmanda E. Janitz
Amanda E. Janitz
Evidence describing paediatric COVID-19 and influenza co-infection is limited because influenza circulation was minimal during the early COVID-19 pandemic. We used the National Clinical Cohort Collaborative, a multicentre electronic health record repository, to describe the characteristics and clinical outcomes of paediatric COVID-19 and influenza co-infections in the United States from March 2020–April 2024. We defined co-infection as COVID-19 and influenza identified <7 days apart. We reported demographics, pre-existing diagnoses, and clinical outcomes and used generalized estimating equation models. We defined clinical outcomes as Severe/Moderate disease (hospitalization, critical care, or death) versus emergency department/outpatient encounters. We repeated analyses using varying co-infection definitions to assess robustness of findings. Among 1.53 million patients, 10,277 were co-infected, and 647 (6%) were hospitalized. Co-infections occurred predominantly among children aged <12 years. The most common pre-existing diagnoses were obesity (24%), asthma (10%), and congenital/genetic conditions (5%). The risk for Severe/Moderate disease was greatest among persons aged 0–4 years (adjusted risk ratio (aRR) 3.05; 95% confidence interval (CI): 2.35–3.97) and those with ≥2 pre-existing diagnoses (aRR 2.89; 95% CI: 2.43–3.43). Similar distributions of disease severity were observed across varying co-infection definitions. This study provides a large-scale epidemiological characterization of paediatric COVID-19 and influenza co-infection and successfully implemented a practical EHR-based co-infection case definition for future analyses.

29 September 2026 in The Lancet Microbe
Verified
Journal Article
Open access
TWTony Wawina-Bokalanga
Tony Wawina-Bokalanga
JOJohn Otokoye Otshudiema
John Otokoye Otshudiema
RKRichard Kitenge-Omasumbu
Richard Kitenge-Omasumbu
ÁOÁine O’TOole
Áine O’TOole
SBSerge Bulanguene-Loso
Serge Bulanguene-Loso
ASAmy J Schuh
Amy J Schuh